Mukka Proteins Faces Financial Challenges Amid Declining Sales and Investor Interest
Mukka Proteins has experienced a recent evaluation adjustment reflecting changes in its market position. The company reported a significant decline in financial performance, with net sales contracting by 24.57% and profit after tax decreasing by 36.38%. Institutional investor participation has also decreased, raising concerns about future growth.
Mukka Proteins, a microcap player in the FMCG sector, has recently undergone an evaluation adjustment that reflects a shift in its market position. The stock's score has been revised, influenced by a variety of underlying trends and financial metrics. The company has reported a significant decline in its financial performance over the past quarters, with net sales for the first nine months showing a contraction of 24.57%. Additionally, the profit after tax has also seen a notable decrease of 36.38%. This trend is compounded by a high Debt to EBITDA ratio of 4.36 times, indicating challenges in servicing its debt obligations.
Institutional investor participation has also waned, with a slight reduction in their stake, now collectively holding 3.96% of the company. This decline in institutional interest may reflect broader concerns regarding Mukka Proteins' ability to sustain growth, as evidenced by its annual net sales growth rate of just 8.60% over the last five years.
Despite these challenges, the company has demonstrated some resilience, with operating profit growing at an annual rate of 50.86%. However, the overall performance indicators suggest a complex landscape for Mukka Proteins moving forward.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
